1. Home
  2. NEPH vs CCEL Comparison

NEPH vs CCEL Comparison

Compare NEPH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.24

Market Cap

39.0M

Sector

Health Care

ML Signal

N/A

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$5.05

Market Cap

41.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEPH
CCEL
Founded
1997
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
41.8M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
NEPH
CCEL
Price
$3.24
$5.05
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $6.25
N/A
AVG Volume (30 Days)
★ 54.8K
11.9K
Earning Date
11-05-2026
10-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1000.00
N/A
EPS
0.12
★ 0.23
Revenue
$18,789,000.00
★ $25,384,279.00
Revenue This Year
$17.81
N/A
Revenue Next Year
$15.90
N/A
P/E Ratio
$27.33
★ $23.26
Revenue Growth
★ 32.67
9.76
52 Week Low
$2.66
$2.72
52 Week High
$6.42
$5.45

Technical Indicators

Market Signals
Indicator
NEPH
CCEL
Relative Strength Index (RSI) 36.24 57.43
Support Level $3.15 $3.14
Resistance Level $3.18 N/A
Average True Range (ATR) 0.23 0.40
MACD -0.02 0.06
Stochastic Oscillator 12.41 75.21

Price Performance

Historical Comparison
NEPH
CCEL

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: